👶
Children's Cancers
Our paediatric oncology program addresses the unique biology of childhood cancers, focusing on improving cure rates while reducing long-term treatment toxicity.
Learn More
Research Themes
Risk-Adapted Therapy Protocols
Genomic risk stratification to intensify treatment for high-risk patients while safely de-escalating therapy for standard-risk children.
Neuroblastoma Biology
Studying MYCN amplification, ALK mutations, and tumour microenvironment in high-risk neuroblastoma to identify novel therapeutic targets.
Late Effects & Survivorship
Long-term follow-up studies tracking endocrine, cardiac, and neurocognitive outcomes in childhood cancer survivors.
Clinical Trials
NCT06234508
RecruitingReduced-Intensity Maintenance Therapy in Standard-Risk ALL
PI: Dr. Shirley Sunder Singh
NCT06234509
ActiveDinutuximab + Irinotecan in Relapsed Neuroblastoma
PI: Dr. Selvaluxmy Ganapathy
Give Hope to Children with Cancer
Donations directly fund treatment for children from economically disadvantaged families and support research into gentler, more effective therapies.
Donate Now